Stem cell transplantation from a space person in a haematological cancer patient

Authors

  • Debajani Deka Department of Anatomy, Pragjyotishpur Medical College, Guwahati, Assam, India
  • Sanjay Mishra AIIMS, Jammu, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20263732

Keywords:

Stem cell , Cancer, Epigenetic

Abstract

Epigenetic changes are a reversible process. The epigenetic changes are: methylation, histone modification, and non-coding RNA. Through processes such as DNA methylation, histone modification and non-coding RNA action, the chromatin state is altered, thereby influencing gene activation. Moreover, epigenetic modifications can respond to environmental exposures. DNA methylation typically silences genes by adding methyl groups to cytosine bases neighbouring guanines; chemical modifications in histone tails can either loosen or tighten DNA winding around histones, affecting accessibility to transcription factors; and non-coding RNAs can interfere with transcription or translation processes.

References

Allen M, Guerrero-Bosagna C. Epigenetic changes and their potential reversibility in mental health disorders. Essays Biochem. 2025;69(3):305-15.

Park-Min KH. Epigenetic regulation of bone cells. Connect Tissue Res. 2017;58(1):76-89.

Arjmand B, Shahrahmani F, Mirzaei A, Emamifar A, Alavi-Moghadam S. The Role of Epigenetic Modifications in Enhancing Bone Marrow Transplantation Efficacy in Cancer. Adv Exp Med Biol. 2025;1499:87-106.

Chang CH, Tsai CC, Cheng CF, Chu TY, Chiang CP, Lee YP, et al. Tumour organoids: A review of culture methods, applications in cancer research, precision medicine, and drug development. Tzu Chi Med J. 2025;37(4):360-70.

Srinageshwar B, Maiti P, Dunbar GL, Rossignol J. Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases. Int J Mol Sci. 2016;17(2):199.

Downloads

Published

2026-10-22

How to Cite

Deka, D., & Mishra, S. (2026). Stem cell transplantation from a space person in a haematological cancer patient. International Journal of Advances in Medicine, 13(6), 491–491. https://doi.org/10.18203/2349-3933.ijam20263732

Issue

Section

Letter to the Editor